Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

Dermato-Endocrinology

Volumn 2, Issue 1, 2010, Pages 26-29

  Schmaltz, Rebecca ^a   Vogt, Thomas ^a   Reichrath, Jörg ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Auto inflammatory syndroms; Fever; TNF receptor; TRAPS; Tumor necrosis factor; Urticaria

Indexed keywords

CASPASE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; GLUCOCORTICOID; HYBRID PROTEIN; I KAPPA B; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEAR FACTOR; P55TNFR IG PROTEIN; TACROLIMUS; TNFRSF1A PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AMYLOIDOSIS; ARTHRALGIA; CHROMOSOME 12; CONJUNCTIVITIS; CORTICOSTEROID THERAPY; DRUG FEVER; ENZYME ACTIVATION; ERYTHEMA; EYE PAIN; FAMILIAL MEDITERRANEAN FEVER; FEVER; HISTOPATHOLOGY; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IMMUNOPATHOGENESIS; INJECTION SITE REACTION; MISSENSE MUTATION; MOLECULAR INTERACTION; MYALGIA; NEPHROTIC SYNDROME; PERIORBITAL EDEMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; RASH; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN DEFECT; SKIN EDEMA; SKIN MANIFESTATION; SKIN PAIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; URTICARIA;

EID: 77956310861     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.2.1.12387     Document Type: Review

References (19)

1. Bar-Eli M, Ehrenfeld M, Levy M, Gallily R, Eliakim M. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci 1981; 281:15-8.
2. Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 1995; 96:994-1002.
3. Dinarello CA, Chusid MJ, Fauci AS, Gallin JI, Dale DC, Wolff SM. Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum 1976; 19:618-22.
4. Domingo C, Touitou I, Bayou A, et al. Familial Mediterranean fever in the "Chuetas" of Mallorca: a question of Jewish origin or genetic heterogeneity. Eur J Hum Genet 2000; 8:242-6.
5. Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with etanercept in patients with TRAPS. N Engl J Med 2000; 343:1044-5.
6. Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology 2003; 42:235-9.
7. Hentgen V, Granel B, Dode C, Cuisset L, Delpech M, Grateau G. Tumor necrosis factor receptor superfamily 1A-associated periodic syndrome (TRAPS). Rev Med Interne 2003; 24:781-5.
8. Horiuchi T, Tsukamoto H, Mitoma H, Tamimoto Y, Yoshizawa S, Harada M, et al. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese. Int J Mol Med 2004; 14:813-8.
9. Hull KM, Drewe E, Aksentijevich I, Dean IJ, Singh H, Powell RJ, et al. TNF receptor-associated periodic syndrome: emerging concepts of an autoinflammatory disorder. Medicine 2002; 81:34968.
10. Masson C, Simon V, Hoppe E, Insalaco P, Cisse I, Audran M. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment and place relative to other periodic joint diseases. Joint Bone Spine 2004; 71:284-90.
11. McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc 1997; 72:806-17.
12. Saulsbury FT, Wispelwey B. Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis and adenitis as a child. J Pediatr 2005; 146:283-5.
13. Siebert S, Fielding CA, Williams BD, Brennan P. Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NFkappaB activation due to decreased surface expression. FEBS Lett 2005; 579:5193-8.
14. Stojanov S, McDermott MF. The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 2005; 7:1-18.
15. Todd I, Radford PM, Draper-Morgan K-A, McIntosh R, Bainbridge S, Dickinson P, et al. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology 2004; 113:65.
16. Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 2000; 136:1487-94.
17. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever. Q J Med 1982; 51:469-80.
18. Yousaf N, Gould DJ, Aganna E, Hammond L, Mirakian RM, Turner MD, et al. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NFkappaB activation. Arthritis Rheum 2005; 52:2906-16.
19. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314:1001-5.